Anti-VEGF therapies, which include VEGF inhibitors, such as bevacizumab and ziv-aflibercept, and VEGF receptor (VEGFR) inhibitors, such as ramucirumab and fruquintinib, block the formation of tumor blood vessels, or angiogenesis [35]. This evidence concerns the gene VEGFA and neoplasm.